Manufacturing News and Research

RSS

Manufacturing is the production of products across all industries, on a large-scale, using machinery.

Biogen Idec first quarter revenues increase 7% to $1.3 billion

Biogen Idec Inc., a global biotechnology leader in the discovery, development, manufacturing and commercialization of innovative therapies, today announced its first quarter 2012 results.

2 May 2012

Nelson-Miller announces acquisition of KDM

Nelson-Miller, Inc., a leading manufacturer of membrane switches and product identification components, announced today that it has acquired KDM from CoActive Technologies.

2 May 2012

Almac acquires high-speed blister line for new Audubon packaging facility

Almac, a leading provider of contract services to the global pharmaceutical and biotech industries, is pleased to announce the acquisition of a state-of-the-art, high-speed blister line for their new 100,000ft2 US commercial packaging facility in Audubon, PA.

2 May 2012

Teleflex launches Hudson RCI Softech Plus to help clinicians

Teleflex Incorporated has announced the introduction of Hudson RCI Softech Plus, a line of oxygen cannulas designed to help clinicians improve patient comfort and reduce DEHP exposure.

2 May 2012

FDA approves Protalix, Pfizer’s ELELYSO for treatment of type 1 Gaucher disease

Pfizer Inc. and Protalix BioTherapeutics, Inc. announced today that the United States (U.S.) Food and Drug Administration (FDA) approved ELELYSO (taliglucerase alfa) for injection, an enzyme replacement therapy (ERT) for the long-term treatment of adults with a confirmed diagnosis of type 1 Gaucher disease.

2 May 2012

Exact Sciences first quarter net loss increases to $10.6 million

Exact Sciences Corp. today announced its financial results for the quarter ended March 31, 2012.

2 May 2012

IDEX announces acquisition of ERC

IDEX Corporation announced today that it has acquired ERC from MH Capital Partners II, L.P.

2 May 2012

Hologic second quarter revenues increase 7.4% to $471.2 million

Hologic, Inc., a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, today announced its results for the second fiscal quarter ended March 24, 2012.

From Hologic, Inc. 30 Apr 2012

Kauffman Foundation sponsors National Conference on Value-driven Engineering

Researchers, health care engineers and medical device experts gathered this week for the inaugural National Conference on Value-driven Engineering to Improve Medical Innovation for U.S. Global Competitiveness assembled by the Austen BioInnovation Institute in Akron (ABIA) and sponsored by the Ewing Marion Kauffman Foundation.

30 Apr 2012

Australian Government must take the lead in tackling antibiotic resistance: NPS Board Chair Dr Janette Randall address to the National Press Club

NPS Board Chair Dr Janette Randall today called on the government to take the lead on a cross sectoral approach towards tackling the antibiotic-resistance crisis facing the Australian community.

26 Apr 2012

Elan first quarter total revenue increases 17% to $288.4 million

Elan Corporation, plc, today reported its first quarter 2012 financial results.

26 Apr 2012

P-bodies have a much broader role in controlling the activities of the cell than previously thought

Cells can reuse the chemical messengers that carry genetic information to the machinery that makes proteins. Sometimes cells shuttle the messengers to storage and later reactivate them to make proteins, according to new research.

26 Apr 2012

Providers can and should work toward 'sustainable anesthesia'

Anesthesia providers can and should begin taking steps toward practicing "sustainable anesthesia," according to the May special issue of Anesthesia & Analgesia, official journal of the International Anesthesia Research Society.

25 Apr 2012

Codexis receives FDA approval for sitagliptin manufacturing process

Codexis, Inc., a developer of industrial enzymes to enable the cost advantaged production of biofuels, bio-based chemicals, and pharmaceutical intermediates, today announced that the FDA has approved a new process co-developed by Codexis for the manufacture of sitagliptin, the active pharmaceutical ingredient in Merck's Januvia.

25 Apr 2012

Cadmium exposure can cause progression of aggressive breast cancer

Studies by researchers at Dominican University of California show that breast cancer cells become increasingly aggressive the longer they are exposed to small concentrations of cadmium, a heavy metal commonly found in cosmetics, food, water and air particles.

24 Apr 2012

Essilor first quarter consolidated revenue increases 21% to €1,269.9M

Essilor International, the world leader in ophthalmic optics, today announced that consolidated revenue for the three months ended March 31, 2012 totaled €1,269.9 million, an increase of 21%, excluding the currency effect, over the year-earlier period.

24 Apr 2012

FDA issues draft guidelines on approval process for use of nanoparticles in food and cosmetics

The United States Food and Drugs Administraton (FDA) has proposed that food companies that want to use tiny engineered particles called nanoparticles in their packaging may have to provide extra testing data to show the products are safe.

23 Apr 2012

Nephros granted rights to market products based on Medica's Medisulfone ultrafiltration technology

Nephros, Inc., a medical device company developing and marketing filtration products for therapeutic applications, infection control, and advanced water purification solutions, today announced that the company has entered into a strategic license and supply agreement with Medica S.p.A.

23 Apr 2012

Aggredyne closes $3 million Series A convertible preferred stock financing

Aggredyne, Inc., a Houston-based biomedical diagnostics company that is defining a new standard for platelet function testing, sold out and closed a $3 million Series A convertible preferred stock financing.

23 Apr 2012

Method to manufacture cartilage from human embryonic stem cells

BioTime, Inc. and its wholly owned subsidiary OrthoCyte Corporation reported today a means of manufacturing cartilage from human embryonic stem cells that is suited for industrial scale-up of a product for the treatment of osteoarthritis.

23 Apr 2012